PRIDE: Preventing Respiratory Illnesses During Childhood Study (PRIDE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00927264|
Recruitment Status : Completed
First Posted : June 24, 2009
Results First Posted : August 24, 2017
Last Update Posted : August 24, 2017
|Condition or disease||Intervention/treatment||Phase|
|Tobacco Smoke Pollution||Behavioral: Motivational Interviewing Intervention for ETS Reduction Behavioral: Educational Program for ETS Reduction||Not Applicable|
About 90% of nonsmoking people in the US are exposed to ETS. More than 50 chemicals identified in ETS have been found to cause cancer and exposure has been linked to heart disease in adults and SIDS, ear infections and numerous respiratory problems, including asthma in children. In 2007, the Environmental Protection Agency and the Office of Head Start-a national program that provides economically disadvantaged children services to enhance their social and cognitive development-announced a new initiative to promote smoke-free homes for children in Head Start programs. Because Head Start reaches high-risk, low-income preschool children, it offers a timely intervention for reducing children's exposure to ETS. Head Start also attempts to engage parents, which is an important component of reducing household ETS exposure among children. This study will determine the effectiveness of a home-delivered, motivational interviewing-based program in reducing ETS exposure and improving lung health among children who are enrolled in the Baltimore City Head Start program and whose households include a smoker.
Participation in this study will last 1 year. First, all participating families will be visited at home by a study staff person who will attach special filters that will track the amount of nicotine in the various rooms of the house. During this initial visit, the participating children will undergo weight and height measurements and saliva sampling. About a week later, the filters will be collected, a 2nd saliva samples will be taken and parents will be interviewed about their family and child's health. Families will then be randomly assigned to one of two groups. Both groups will received educational information about reducing tobacco smoke exposure. One group will also receive the home-delivered, motivational interviewing-based program aimed to reduce ETS. This program will consist of 2 home visits and 2 phone calls, both led by health counselor who will teach participants how to reduce their child's exposure to tobacco smoke. The home visits will occur during Weeks 1 & 2 and the phone calls will occur during Weeks 3 & 6. Follow-up visits for all participating families will occur at Months 3,6 and 12 and will involve repeat filter testing, saliva monitoring and interviews.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||350 participants|
|Intervention Model:||Factorial Assignment|
|Masking Description:||For masking we were unable to mask the caregiver and child participant since they knew if they were receiving intervention component. The investigator was masked, but outcome assessor may have known group assignment.|
|Official Title:||A+ Head Start Intervention for Smoke Free Homes|
|Study Start Date :||January 2009|
|Actual Primary Completion Date :||January 2013|
|Actual Study Completion Date :||June 2013|
Motivational Interviewing Intervention Plus Education
Caregivers will receive a home-based motivational interviewing intervention for ETS reduction plus an educational program for ETS reduction.
Behavioral: Motivational Interviewing Intervention for ETS Reduction
The intervention is designed to motivate caregivers to reduce a child's ETS exposure by establishing a complete home and car smoking ban and by considering smoking cessation. Caregivers will receive 2 home visits & 2 telephone session, both with a health counselor. Caregivers will be provided with feedback on air nicotine levels and child salivary cotinine levels. The main target for the intervention will be the primary caregiver of the child because the primary caregiver is ultimately responsible for protecting the child from ETS exposure. Any and all household members may participate in the intervention visits but are not required to do so.
Active Comparator: Education Only
Caregivers will receive only educational program for ETS reduction.
Behavioral: Educational Program for ETS Reduction
An Environmental Protection Agency-based educational program that will consist of information about reducing tobacco smoke exposure.
- Air Nicotine Levels [ Time Frame: Measured at Baseline, 3, 6 and 12 months ]Air nicotine levels were an indicator of child's exposure to environmental tobacco smoke (ETS)
- ETS Reduction, as Measured by Child's Cotinine Levels [ Time Frame: Measured at Baseline, 3, 6 and 12 months ]Child salivary cotinine will be a measure to evaluate environmental tobacco smoke (ETS) reduction
- Respiratory Function of Child by Self Report of Parent [ Time Frame: Measured at Baseline, 3, 6, and 12 months ]Number of cold infections child experienced in previous 3 months, reported by caregiver
- Health Care Utilization by Child- Self Report From Parent/Caregiver [ Time Frame: Measured at baseline and 3, 6 and 12 months ]Parent caregiver reported urgent care visits, number of hospitalizations, and number of emergency department visits in the 12 months prior for child enrolled in study
- Number of Participants Who Report Endorsing a Home Smoking Ban [ Time Frame: Measured at baseline, 3, 6 and 12 months ]Number of participants endorsing presence of home smoking ban
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00927264
|United States, Maryland|
|Johns Hopkins University|
|Baltimore, Maryland, United States, 21206|
|Principal Investigator:||Cynthia S Rand, PhD||Johns Hopkins University|